Clinical Trials
5 trialsNCT05768139 2026-05-22
PIKALO-1
Eli Lilly and Company
Phase 1/2 Recruiting
NCT04000529 2025-09-30
Phase Ib Study of TNO155 in Combination With Spartalizumab or Ribociclib in Selected Malignancies
Novartis
Phase 1 Terminated
NCT04213404 2022-04-21
RISE-HN
National Taiwan University Hospital
Phase 1 Unknown
NCT02429089 2020-01-09
CETLEE011
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Phase 1 Terminated
NCT03179956 2019-02-25
Impact of Ribociclib on Head and Neck Squamous Cell Cancer
Fox Chase Cancer Center
Phase EARLY_PHASE1 Terminated